Φορτώνει......
Emerging targets in cancer immunotherapy: beyond CTLA-4 and PD-1
Manipulation of co-stimulatory or co-inhibitory checkpoint proteins allows for the reversal of tumor-induced T-cell anergy observed in cancer. The field has gained credence given success with CTLA-4 and PD-1 inhibitors. These molecules include immunoglobulin family members and the B7 subfamily as we...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Immunotherapy |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Future Medicine Ltd
2015
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4976877/ https://ncbi.nlm.nih.gov/pubmed/26567614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/imt.15.78 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|